International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Vaccine

Topics

Biology

Cancer Oncology

Medicine

Epidemiology

Immunology

Show all topics

DOI

10.1016/j.vaccine.2009.10.145